Conjunctivitis Drugs Market Shows Strong Growth with Leading Players By 2027
Conjunctivitis is an eye condition characterized by
inflammation of external white part and eyelids. Although this medical
condition is caused due to various factors but bacterial and virus are most
prominent causes accounting for more than 50% cases of conjunctivitis. The market for conjunctivitis drugs is facing
stagnant growth in developed regions. Also, a number of patents which have
expired such as Moxeza, Besivance, Vigamox, and Zymaxid have dampened the
market growth. The market is further characterized by easy entry but high
competition which has resulted into greater penetration by generics.
Conjunctivitis
Drugs Market Is Expected to Grow at a CAGR of 3.1% by 2022 .The best
strategy for firms is market development especially the Asian Pacific market
which is poised to lead the growth of the global market in the near future. The
market is further dampened by the better efficacy and broad spectrum of
anti-bacterial drugs led by quinolones. Quinolones especially Fluoroquinolones
has a dominant market share for conjunctivitis. The research pipeline is
somewhat weak with many other classes of antibiotics exhibiting greater
toxicity. Thus, quinolones have immensely raised the acceptable bar for newer
drugs.
Request
Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/2513
The market is chiefly driven by unmet needs in developing
regions along with greater awareness and rising incomes in these regions. These
reasons along with contagious nature of the disease along with rise of drug
resistance also driving the market of other antibiotics which has greater
toxicity such as macrolide class. Off label drug use is also one of the market
drivers due to cheap generics and greater availability of these drugs.
Test the market data and market information presented in
more than 60 market data tables and figures spread over 84 pages of the project
report. Avail the in-depth table of content (TOC) & market synopsis on “The
Global Conjunctivitis Drugs Market Research Report - Forecast to 2022”.
Global Conjunctivitis Drugs market:
The global conjunctivitis drugs market has been evaluated to
be growing and it is expected that it will touch high growth figures in future.
The global conjunctivitis drugs market is expected to grow with CAGR of 3.1% in
future. Market development and diversification into Asian Pacific market seems
to have better strategy for the current situation.
Market Key Players:
Major participants of this market are: Akorn
Pharmaceuticals, Alcon/ Novartis AG, Allergan Plc, Bausch & Lomb, Valeant
Pharmaceuticals, Merck & Co. Inc., Actavis Plc., Pfizer Inc. and others.
Segmentation:
Global conjunctivitis drugs market has been segmented on the
basis of conjunctivitis type which comprises of viral, bacterial, allergic and
others types of conjunctivitis. On the basis of drug class; market is segmented
into antibiotics (quinolones, aminoglycosides, macrolides and others), mast
cell stabilizers, steroids and others. On the basis of route of administration;
market is segmented into topical, oral and intra-vitreal. On the basis of end
users; market is segmented into hospitals and self-administered.
Regional Analysis:
Depending on geographic region, conjunctivitis drugs market is segmented into four key regions: America, Europe, Asia Pacific, and Middle East & Africa. Globally, America is the largest market for conjunctivitis drugs followed by Europe. However, the developed regions market is stagnant and any future growth will be led by the developing regions especially Asia pacific region. The unmet drug needs and greater awareness are prime driver of the conjunctivitis drugs market. Greater exposure to allergens and infective agents is also driving the market’s growth.
Browse Detailed TOC
with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/conjunctivitis-drugs-market-2513
About Market
Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact:
Akash Anand
Market Research
Future
+1 646 845 9312
Comments
Post a Comment